CVE-2025-53377

Public Exploit
WebGia allows Cross-Site Scripting (XSS) in cadastro_dependente_pessoa_nova.php via the id_funcionario parameter

Description

WeGIA is a web manager for charitable institutions. A Reflected Cross-Site Scripting (XSS) vulnerability was identified in the cadastro_dependente_pessoa_nova.php endpoint of the WeGIA application. This vulnerability allows attackers to inject malicious scripts in the id_funcionario parameter. This vulnerability is fixed in 3.4.3.

Category

2.0
CVSS
Severity: Low
CVSS 4.0 •
CVSS 3.1 •
EPSS 0.05%
Vendor Advisory github.com
Affected: LabRedesCefetRJ WeGIA
Published at:
Updated at:

References

Link Tags
https://github.com/LabRedesCefetRJ/WeGIA/security/advisories/GHSA-qgrq-qjq6-h6gj vendor advisory exploit
https://github.com/LabRedesCefetRJ/WeGIA/commit/8ab726c9f4d0fce7ad6c66640c3126f95f73ddd7 patch

Frequently Asked Questions

What is the severity of CVE-2025-53377?
CVE-2025-53377 has been scored as a low severity vulnerability.
How to fix CVE-2025-53377?
To fix CVE-2025-53377, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2025-53377 being actively exploited in the wild?
It is possible that CVE-2025-53377 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2025-53377?
CVE-2025-53377 affects LabRedesCefetRJ WeGIA.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.